Buchumschlag

A new fibrin-heparine coated self-expanding stent for the rescue treatment of intracranial stenosis: a multicentric study

Introduction: Rescue intracranial stenting is necessary to provide sufficient recanalization after mechanical thrombectomy (MT) in patients with acute large vessel occlusions (LVO) due to an underlying intracranial atherosclerotic disease (ICAD). The CREDO heal is a novel stent that provides a poten...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Dorn, Franziska (VerfasserIn) , Möhlenbruch, Markus Alfred (VerfasserIn) , Jesser, Jessica (VerfasserIn) , Vollherbst, Dominik (VerfasserIn) , Schob, Stefan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: March 2025
In: Clinical neuroradiology
Year: 2025, Jahrgang: 35, Heft: 1, Pages: 43-50
ISSN:1869-1447
DOI:10.1007/s00062-024-01448-6
Online-Zugang:Resolving-System, kostenfrei: https://doi.org/10.1007/s00062-024-01448-6
Resolving-System, kostenfrei: https://doi.org/10.25673/118300
Volltext
Verfasserangaben:Franziska Dorn, Markus Moehlenbruch, Jessica Jesser, Dominik Vollherbst, Stefan Schob [und einige weitere]
Beschreibung
Zusammenfassung:Introduction: Rescue intracranial stenting is necessary to provide sufficient recanalization after mechanical thrombectomy (MT) in patients with acute large vessel occlusions (LVO) due to an underlying intracranial atherosclerotic disease (ICAD). The CREDO heal is a novel stent that provides a potentially lower thrombogenicity due to surface modification. We present the first multicentric experience with the CREDO heal for acute rescue stenting. Methods: Data of 81 patients who underwent rescue stenting after MT at 12 centers in Germany and Spain were prospectively collected and retrospectively evaluated. Results: Final mTICI 2b‑3 was reached in 95.1% after median two MT maneuvers and stenting. Four periprocedural complications resulted in clinical deterioration (4.9%). Intraparenchymal hemorrhage occurred in one patient (1.2%) and functional independence at FU was reached by 42% of the patients. Most interventions were performed under Gp IIb/IIIa inhibitors. Conclusion: CREDO heal was effective and safe in our case series. However, more data is needed to define the optimal antithrombotic regime. The use under single antiplatelet medication is not supported by our study.
Beschreibung:Gesehen am 24.02.2025
Beschreibung:Online Resource
ISSN:1869-1447
DOI:10.1007/s00062-024-01448-6

Ähnliche Einträge